Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $47 | $50 | $63 | $33 |
| - Cash | $15 | $16 | $15 | $18 |
| + Debt | $10 | $10 | $10 | $21 |
| Enterprise Value | $42 | $44 | $59 | $36 |
| Revenue | $8 | $11 | $12 | $10 |
| % Growth | -23.5% | -7.5% | 12.2% | – |
| Gross Profit | $7 | $9 | $10 | $8 |
| % Margin | 88.1% | 81.4% | 87.8% | 81.1% |
| EBITDA | -$1 | $1 | $3 | $0 |
| % Margin | -9.6% | 6.5% | 23.3% | 0.4% |
| Net Income | -$2 | -$1 | $1 | -$2 |
| % Margin | -23.4% | -6.8% | 10.7% | -18.2% |
| EPS Diluted | -0.13 | -0.05 | 0.08 | -0.14 |
| % Growth | -160% | -162.5% | 157.1% | – |
| Operating Cash Flow | $0 | $1 | $4 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $1 | $4 | $2 |